BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang H, Cao Y, Pei H, Wang H, Ma L, Wang Z, Diao X, Yang Y, Liu N, Wei Y, Li H. Shenmayizhi Formula Combined with Ginkgo Extract Tablets for the Treatment of Vascular Dementia: A Randomized, Double-Blind, Controlled Trial. Evid Based Complement Alternat Med 2020;2020:8312347. [PMID: 32774430 DOI: 10.1155/2020/8312347] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun C, Liu M, Liu J, Zhang T, Zhang L, Li H, Luo Z. ShenmaYizhi Decoction Improves the Mitochondrial Structure in the Brain and Ameliorates Cognitive Impairment in VCI Rats via the AMPK/UCP2 Signaling Pathway. Neuropsychiatr Dis Treat 2021;17:1937-51. [PMID: 34168453 DOI: 10.2147/NDT.S302355] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 Torres Crigna A, Link B, Samec M, Giordano FA, Kubatka P, Golubnitschaja O. Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine. EPMA J 2021;:1-41. [PMID: 34367381 DOI: 10.1007/s13167-021-00248-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhang H, Chen H, Pei H, Wang H, Ma L, Li H. The Effect of Guilingji Capsules on Vascular Mild Cognitive Impairment: A Randomized, Double-Blind, Controlled Trial. Evid Based Complement Alternat Med 2022;2022:4778163. [PMID: 35116067 DOI: 10.1155/2022/4778163] [Reference Citation Analysis]